US-based DiscoveRx’s BioSeek division launched BioMAP panel, a primary human cell-based assay platform, for oncology research. The BioMAP panel comprising primary human cell-based tumor-host model systems allows the researchers to ...
Tags: Oncology Research, Biomap Panel
US-based pharmaceutical manufacturer and marketer Forest Laboratories (FRX) has received qualified infectious disease product (QIDP) designation for its ceftazidime/avibactam drug from the US Food and Drug Administration (FDA). Currently ...
Tags: drug, Forest Laboratories
The US Food and Drug Administration (FDA) has approved breakthrough therapy designation for Danish biotechnology company Genmab and British pharmaceutical company GlaxoSmithKline’s (GSK) Arzerra (ofatumumab) in combination with ...
Tags: therapy designation, Medicine
Managed Health Care Associates (MHA) and CoverMyMeds have joined hands to provide a co-branded solution to MHA's pharmacy members for facilitating a more efficient process for completing and submitting drug prior authorizations (PA). ...
Tags: MHA Partners, CoverMyMeds
SeaChange Pharmaceuticals has introduced its similarity ensemble approach (SEA) software called SEAware for predictive matching of drugs with disease and toxicity targets. SEAware provides analysis and visualization tools for prediction ...
NeoTract has received an approval from the US Food and Drug Administration (FDA) to market its UroLift system, designed to relieve low or blocked urine flow in men age 50 and older with an enlarged prostate (benign prostatic hyperplasia). ...
Tags: Prostate Implant, Neotract
Champions Oncology (Champions), a developer of advanced technology solutions and services to personalize the development and use of oncology drugs, has signed a new discovery and drug development partnership with Teva Pharmaceutical ...
Tags: Champions Oncology
Schwebel Baking has recalled 18,979 units of Golden Rich Buns with Honey, as they contain egg which is not mentioned on the labeling, according to the US Food and Drug Administration (FDA). The product subject to recall is Golden Rich ...
Tags: Schwebel, Golden Rich Buns
Editor's note: Just in time for pre-Interbike reading, BRAIN's longtime legal analyst, Steve Hansen, takes a look at the implications of recent employer liability cases involving hosting parties where alcohol was served or was present. ...
Tags: Transportation
The Israeli Ministry of Health has granted an approval to Medigus for registering its SRS system, which is designed to treat gastroesophageal reflux disease, in the Israeli Register of Medical Equipment and Accessories (MEA). The SRS ...
Tags: SRS system, Medicine
Dfine, a manufacturer of spinal disease treatment devices, has obtained CE Mark approval for its STAR tumor ablation system, designed to treat painful metastatic spinal tumors. The STAR tumor ablation system uses radiofrequency (RF) ...
Tags: Dfine, Tumor Ablation System
US-based Boston Scientific has completed the patient enrolment in the EVOLVE II clinical trial, designed to assess the safety and effectiveness of SYNERGY stent system and support the US Food and Drug Administration and Japanese regulatory ...
Tags: Clinical Trial, Medicine
CAS Medical Systems (CASMed), a medical technology company, has announced the initial sales of its next-generation Fore-Sight Elite cerebral oximetry products. The Fore-Sight Elite is lighter and more portable than the earlier model, with ...
Israel-based medical device company Brainsway has received an investigational device exemption (IDE) from the US Food and Drug Administration (FDA) to evaluate the efficacy of its Deep TMS device in multi-center smoking cessation study. ...
Tags: Smoking Cessation Study, Health, Medicine
RTI Surgical, provider of orthopedic and other biologic implants, has received a positive feedback from the US Food and Drug Administration (FDA), following its two- day inspection at its Alachua processing facility in Florida. Earlier on ...